$2.72 Billion is the total value of Redmile Group, LLC's 77 reported holdings in Q1 2024. The portfolio turnover from Q4 2023 to Q1 2024 was 35.7% .
| Value | Shares | ↓ Weighting | ||||||
|---|---|---|---|---|---|---|---|---|
| KRYS | Sell | KRYSTAL BIOTECH INC | $268,362,923 | +24.8% | 1,508,250 | -13.0% | 9.85% | +28.1% |
| FOLD | Sell | AMICUS THERAPEUTICS INC | $156,170,829 | -25.8% | 13,257,286 | -10.6% | 5.73% | -23.8% |
| IMNM | Buy | IMMUNOME INC | $120,674,193 | +190.7% | 4,889,554 | +26.0% | 4.43% | +198.2% |
| SRRK | Buy | SCHOLAR ROCK HLDG CORP | $114,012,274 | -5.3% | 6,419,610 | +0.3% | 4.18% | -2.8% |
| FATE | FATE THERAPEUTICS INC | $96,660,878 | +96.3% | 13,169,057 | 0.0% | 3.55% | +101.4% | |
| RGNX | Buy | REGENXBIO INC | $95,901,285 | +42.1% | 4,551,556 | +21.0% | 3.52% | +45.8% |
| DCPH | Buy | DECIPHERA PHARMACEUTICALS IN | $83,316,194 | +7.6% | 5,296,643 | +10.3% | 3.06% | +10.4% |
| KYMR | Sell | KYMERA THERAPEUTICS INC | $69,710,378 | +50.1% | 1,734,089 | -4.9% | 2.56% | +54.1% |
| ADCT | Sell | ADC THERAPEUTICS SA | $68,558,784 | +169.4% | 15,269,217 | -0.4% | 2.52% | +176.5% |
| STOK | Buy | STOKE THERAPEUTICS INC | $68,486,162 | +395.9% | 5,073,049 | +93.2% | 2.51% | +408.9% |
| AUGX | AUGMEDIX INC | $66,995,537 | -30.1% | 16,380,327 | 0.0% | 2.46% | -28.2% | |
| NRIX | Buy | NURIX THERAPEUTICS INC | $65,900,335 | +96.1% | 4,483,016 | +37.7% | 2.42% | +101.2% |
| Sell | BIOHAVEN LTD | $63,617,650 | +2.9% | 1,163,241 | -19.5% | 2.34% | +5.6% | |
| BEAM | Buy | BEAM THERAPEUTICS INC | $62,102,546 | +59.6% | 1,879,617 | +31.5% | 2.28% | +63.7% |
| Sell | ZYMEWORKS INC | $58,499,595 | -2.8% | 5,560,798 | -4.0% | 2.15% | -0.2% | |
| LIVN | Sell | LIVANOVA PLC | $58,053,413 | -1.3% | 1,037,780 | -8.7% | 2.13% | +1.3% |
| STTK | Sell | SHATTUCK LABS INC | $50,202,472 | +25.3% | 5,615,489 | -0.1% | 1.84% | +28.6% |
| ALXO | Buy | ALX ONCOLOGY HLDGS INC | $48,240,575 | -11.5% | 4,326,509 | +18.2% | 1.77% | -9.1% |
| Sell | NEUROGENE INC | $47,604,327 | +159.4% | 935,252 | -1.2% | 1.75% | +166.3% | |
| AKRO | Buy | AKERO THERAPEUTICS INC | $46,950,813 | +81.2% | 1,858,702 | +67.5% | 1.72% | +85.9% |
| Buy | ABSCI CORPORATION | $46,878,835 | +39.0% | 8,253,316 | +2.8% | 1.72% | +42.7% | |
| PLRX | Buy | PLIANT THERAPEUTICS INC | $46,148,578 | -5.5% | 3,097,220 | +14.9% | 1.69% | -3.0% |
| SLN | New | SILENCE THERAPEUTICS PLCads | $43,797,650 | – | 2,027,669 | +100.0% | 1.61% | – |
| IDYA | Sell | IDEAYA BIOSCIENCES INC | $40,487,111 | +21.6% | 922,678 | -1.4% | 1.49% | +24.8% |
| FDMT | New | 4D MOLECULAR THERAPEUTICS IN | $40,189,064 | – | 1,261,427 | +100.0% | 1.48% | – |
| ANNX | ANNEXON INC | $39,457,872 | +57.9% | 5,503,190 | 0.0% | 1.45% | +62.0% | |
| BSX | Sell | BOSTON SCIENTIFIC CORP | $38,417,822 | -4.1% | 560,926 | -19.1% | 1.41% | -1.6% |
| CLDX | Sell | CELLDEX THERAPEUTICS INC NEW | $37,624,174 | -4.5% | 896,454 | -9.8% | 1.38% | -2.1% |
| KROS | New | KEROS THERAPEUTICS INC | $36,575,897 | – | 552,506 | +100.0% | 1.34% | – |
| CTLT | Sell | CATALENT INC | $35,702,593 | -27.8% | 632,464 | -42.5% | 1.31% | -25.9% |
| IMVT | Sell | IMMUNOVANT INC | $31,328,455 | -23.9% | 969,621 | -0.8% | 1.15% | -21.9% |
| REPL | Sell | REPLIMUNE GROUP INC | $30,473,961 | -6.5% | 3,729,983 | -3.5% | 1.12% | -4.0% |
| ABT | Sell | ABBOTT LABS | $29,821,088 | +2.0% | 262,371 | -1.2% | 1.10% | +4.8% |
| IGMS | Buy | IGM BIOSCIENCES INC | $29,649,413 | +20.1% | 3,072,478 | +3.4% | 1.09% | +23.2% |
| ALGN | Buy | ALIGN TECHNOLOGY INC | $28,612,660 | +108.5% | 87,255 | +74.2% | 1.05% | +113.8% |
| COGT | Buy | COGENT BIOSCIENCES INC | $26,628,685 | +55.4% | 3,962,602 | +36.0% | 0.98% | +59.4% |
| ETNB | Buy | 89BIO INC | $26,359,548 | +19.8% | 2,264,566 | +15.0% | 0.97% | +22.9% |
| CI | New | THE CIGNA GROUP | $23,765,338 | – | 65,435 | +100.0% | 0.87% | – |
| EVH | Sell | EVOLENT HEALTH INCcl a | $22,270,050 | -19.3% | 679,172 | -18.7% | 0.82% | -17.2% |
| VERV | Sell | VERVE THERAPEUTICS INC | $21,307,959 | -11.1% | 1,604,515 | -6.6% | 0.78% | -8.8% |
| ENTRADA THERAPEUTICS INC | $18,190,525 | -6.1% | 1,283,735 | 0.0% | 0.67% | -3.6% | ||
| HCA | Sell | HCA HEALTHCARE INC | $17,505,989 | -2.2% | 52,487 | -20.6% | 0.64% | +0.5% |
| ANTM | Buy | ELEVANCE HEALTH INC | $16,190,374 | +48.8% | 31,223 | +35.3% | 0.59% | +52.7% |
| ARDX | New | ARDELYX INC | $16,020,288 | – | 2,194,560 | +100.0% | 0.59% | – |
| New | BOUNDLESS BIO INC | $15,874,985 | – | 1,114,034 | +100.0% | 0.58% | – | |
| SYK | Sell | STRYKER CORPORATION | $15,476,446 | -2.7% | 43,246 | -18.6% | 0.57% | -0.2% |
| GRTS | Sell | GRITSTONE BIO INC | $14,790,543 | +23.5% | 5,755,075 | -2.0% | 0.54% | +26.9% |
| Buy | PRIME MEDICINE INC | $14,520,450 | +23.7% | 2,074,350 | +56.6% | 0.53% | +26.9% | |
| ICLR | New | ICON PLC | $12,413,017 | – | 36,949 | +100.0% | 0.46% | – |
| PGNY | New | PROGYNY INC | $12,240,962 | – | 320,864 | +100.0% | 0.45% | – |
| Buy | VENTYX BIOSCIENCES INC | $11,902,693 | +2225.7% | 2,164,126 | +944.4% | 0.44% | +2327.8% | |
| ISRG | Sell | INTUITIVE SURGICAL INC | $11,791,513 | -35.6% | 29,546 | -45.5% | 0.43% | -33.9% |
| CYTK | New | CYTOKINETICS INC | $11,329,776 | – | 161,600 | +100.0% | 0.42% | – |
| DGX | New | QUEST DIAGNOSTICS INC | $11,161,140 | – | 83,849 | +100.0% | 0.41% | – |
| MCK | New | MCKESSON CORP | $11,116,553 | – | 20,707 | +100.0% | 0.41% | – |
| NUVB | NUVATION BIO INC | $11,032,873 | +141.1% | 3,031,009 | 0.0% | 0.40% | +147.0% | |
| ELAN | New | ELANCO ANIMAL HEALTH INC | $11,005,915 | – | 676,039 | +100.0% | 0.40% | – |
| BPMC | New | BLUEPRINT MEDICINES CORP | $10,724,872 | – | 113,060 | +100.0% | 0.39% | – |
| PEN | Sell | PENUMBRA INC | $9,956,729 | -58.4% | 44,613 | -53.2% | 0.36% | -57.4% |
| RPTX | Sell | REPARE THERAPEUTICS INC | $9,496,782 | -39.5% | 2,016,302 | -6.2% | 0.35% | -37.8% |
| APLS | New | APELLIS PHARMACEUTICALS INC | $9,110,900 | – | 155,000 | +100.0% | 0.33% | – |
| STXS | Sell | STEREOTAXIS INC | $8,635,963 | +45.0% | 3,308,798 | -2.8% | 0.32% | +48.8% |
| CABA | Sell | CABALETTA BIO INC | $7,554,612 | -75.8% | 442,826 | -67.8% | 0.28% | -75.2% |
| LVTX | LAVA THERAPEUTICS NV | $6,907,659 | +110.8% | 2,074,372 | 0.0% | 0.25% | +117.1% | |
| ATRA | Buy | ATARA BIOTHERAPEUTICS INC | $6,428,736 | +37.7% | 9,263,309 | +1.7% | 0.24% | +41.3% |
| INVIVYD INC | $6,396,819 | +12.7% | 1,440,725 | 0.0% | 0.24% | +15.8% | ||
| ACIU | Buy | AC IMMUNE SA | $5,940,812 | -40.6% | 2,007,031 | +0.4% | 0.22% | -39.1% |
| RAPT | Buy | RAPT THERAPEUTICS INC | $5,948,334 | -34.7% | 662,398 | +80.6% | 0.22% | -33.1% |
| ESTA | New | ESTABLISHMENT LABS HLDGS INC | $5,819,957 | – | 114,341 | +100.0% | 0.21% | – |
| ALLK | Sell | ALLAKOS INC | $4,348,356 | -56.6% | 3,451,076 | -6.0% | 0.16% | -55.3% |
| XERIS BIOPHARMA HOLDINGS INC | $2,312,957 | -6.0% | 1,046,587 | 0.0% | 0.08% | -3.4% | ||
| ACHL | ACHILLES THERAPEUTICS PLCsponsored ads | $2,010,111 | +40.6% | 1,608,089 | 0.0% | 0.07% | +45.1% | |
| ALVR | ALLOVIR INC | $1,440,326 | +11.0% | 1,907,969 | 0.0% | 0.05% | +15.2% | |
| FLDM | New | STANDARD BIOTOOLS INC | $1,115,520 | – | 411,631 | +100.0% | 0.04% | – |
| ADAP | ADAPTIMMUNE THERAPEUTICS PLCsponds adr | $1,130,659 | +99.2% | 715,607 | 0.0% | 0.04% | +105.0% | |
| HOOK | HOOKIPA PHARMA INC | $757,404 | -12.1% | 1,063,769 | 0.0% | 0.03% | -9.7% | |
| TKNO | Buy | ALPHA TEKNOVA INC | $433,776 | -27.8% | 171,453 | +6.5% | 0.02% | -23.8% |
| BCEL | Exit | ATRECA INC | $0 | – | -442,653 | -100.0% | -0.00% | – |
| NVTA | Exit | INVITAE CORP | $0 | – | -1,474,026 | -100.0% | -0.03% | – |
| Exit | SOMALOGIC INC | $0 | – | -370,839 | -100.0% | -0.03% | – | |
| Exit | MEDAVAIL HOLDINGS INC | $0 | – | -692,082 | -100.0% | -0.11% | – | |
| Exit | SCIENCE 37 HOLDINGS INC | $0 | – | -990,412 | -100.0% | -0.19% | – | |
| CRL | Exit | CHARLES RIV LABS INTL INC | $0 | – | -86,782 | -100.0% | -0.73% | – |
| SPY | Exit | SPDR S&P 500 ETF TRtr unit | $0 | – | -142,500 | -100.0% | -2.42% | – |
| Exit | RAYZEBIO INC | $0 | – | -1,857,706 | -100.0% | -4.13% | – | |
| IMGN | Exit | IMMUNOGEN INC | $0 | – | -16,423,922 | -100.0% | -17.42% | – |
Original filings
The following EDGAR filing(s) were analyzed to create this report:
- View 13F-HR filed 2024-05-15
Signatures
The EDGAR filing(s) were signed by:
Top long-term holdings
| Name | Quarters owned | Latest quarter owned | Max weighting |
|---|---|---|---|
| AMICUS THERAPEUTICS INC | 46 | Q2 2024 | 10.1% |
| ATARA BIOTHERAPEUTICS INC | 38 | Q1 2024 | 6.4% |
| FATE THERAPEUTICS INC | 37 | Q2 2024 | 17.2% |
| INVITAE CORP | 33 | Q4 2023 | 2.7% |
| REGENXBIO INC | 31 | Q2 2024 | 3.8% |
| IMMUNOGEN INC | 28 | Q4 2023 | 17.4% |
| CLOVIS ONCOLOGY INC | 27 | Q1 2020 | 6.7% |
| DECIPHERA PHARMACEUTICALS IN | 27 | Q1 2024 | 7.0% |
| CASTLIGHT HEALTH INC SAN FRAN COM STK | 27 | Q1 2021 | 2.5% |
| ARRAY BIOPHARMA INC | 26 | Q2 2019 | 12.6% |
View Redmile Group, LLC's complete holdings history.
Latest significant ownerships (13-D/G)
| Filed | Shares | Percentage | |
|---|---|---|---|
| FATE THERAPEUTICS INC | March 25, 2024 | 17,619,095 | 14.9% |
| Science 37 Holdings, Inc.Sold out | March 13, 2024 | 0 | 0.0% |
| Absci Corp | March 05, 2024 | 8,282,016 | 7.0% |
| ADC Therapeutics SA | February 14, 2024 | 15,328,317 | 18.8% |
| Akero Therapeutics, Inc. | February 14, 2024 | 1,109,476 | 2.0% |
| ALX ONCOLOGY HOLDINGS INC | February 14, 2024 | 4,909,264 | 9.6% |
| AMICUS THERAPEUTICS, INC. | February 14, 2024 | 21,957,926 | 7.3% |
| Annexon, Inc. | February 14, 2024 | 8,083,776 | 9.9% |
| Ayala Pharmaceuticals, Inc. | February 14, 2024 | 211,014 | 1.9% |
| Deciphera Pharmaceuticals, Inc. | February 14, 2024 | 8,359,768 | 9.9% |
View Redmile Group, LLC's complete significant-ownership history.
Latest filings
| Type | Filed |
|---|---|
| SC 13G/A | 2024-09-13 |
| N-PX | 2024-09-03 |
| 13F-HR | 2024-08-14 |
| SC 13D/A | 2024-07-19 |
| 4 | 2024-07-03 |
| 4 | 2024-07-02 |
| 4 | 2024-06-21 |
| 4 | 2024-06-18 |
| 4 | 2024-06-14 |
| 4 | 2024-06-11 |
View Redmile Group, LLC's complete filings history.
All filings
- Holdings (13F-HR)
- Significant ownership (13-D/G)
- Insider transactions (4, 5, 6)
- Events (8-K)
- Shareholder votes (proxy)
View complete filings history.